Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 6,762 | 6,816 | 6,097 | 8,143 | 6,177 |
| Operating Income | -6,762 | -6,816 | -6,097 | -8,143 | -6,177 |
| Other Income | 30 | 27 | 25 | 33 | 9 |
| Pre-tax Income | -6,732 | -6,789 | -6,072 | -8,110 | -6,168 |
| Net Income Continuous | -6,732 | -6,789 | -6,072 | -8,110 | -6,168 |
| Net Income | $-6,732 | $-6,789 | $-6,072 | $-8,110 | $-6,168 |
| EPS Basic Total Ops | -0.34 | -0.33 | -0.31 | -0.42 | -0.38 |
| EPS Basic Continuous Ops | -0.34 | -0.34 | -0.31 | -0.42 | -0.38 |
| EPS Diluted Total Ops | -0.34 | -0.33 | -0.31 | -0.42 | -0.38 |
| EPS Diluted Continuous Ops | -0.34 | -0.34 | -0.31 | -0.42 | -0.38 |
| EBITDA(a) | $-6,696 | $-6,749 | $-6,032 | $-8,134 | $-6,173 |